These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1265 related items for PubMed ID: 20488410
1. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. Guagliumi G, Musumeci G, Sirbu V, Bezerra HG, Suzuki N, Fiocca L, Matiashvili A, Lortkipanidze N, Trivisonno A, Valsecchi O, Biondi-Zoccai G, Costa MA, ODESSA Trial Investigators. JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410 [Abstract] [Full Text] [Related]
2. Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study. Guagliumi G, Sirbu V, Bezerra H, Biondi-Zoccai G, Fiocca L, Musumeci G, Matiashvili A, Lortkipanidze N, Tahara S, Valsecchi O, Costa M. JACC Cardiovasc Interv; 2010 Jun; 3(6):680-7. PubMed ID: 20630463 [Abstract] [Full Text] [Related]
5. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods. Poerner TC, Otto S, Gassdorf J, Janiak F, Danzer C, Ferrari M, Figulla HR. EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737 [Abstract] [Full Text] [Related]
10. Tissue coverage and neointimal hyperplasia in overlap versus nonoverlap segments of drug-eluting stents 9 to 13 months after implantation: in vivo assessment with optical coherence tomography. Gutiérrez-Chico JL, Räber L, Regar E, Okamura T, di Mario C, van Es GA, Windecker S, Serruys PW. Am Heart J; 2013 Jul; 166(1):83-94. PubMed ID: 23816026 [Abstract] [Full Text] [Related]
11. Impact of drug release kinetics on vascular response to different zotarolimus-eluting stents implanted in patients with long coronary stenoses: the LongOCT study (Optical Coherence Tomography in Long Lesions). Guagliumi G, Ikejima H, Sirbu V, Bezerra H, Musumeci G, Lortkipanidze N, Fiocca L, Tahara S, Vassileva A, Matiashvili A, Valsecchi O, Costa M. JACC Cardiovasc Interv; 2011 Jul; 4(7):778-85. PubMed ID: 21777886 [Abstract] [Full Text] [Related]
12. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W. JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443 [Abstract] [Full Text] [Related]
13. Tissue coverage of paclitaxel and sirolimus eluting stents in long term follow-up: optical coherence tomography study. Kochman J, Pietrasik A, Rdzanek A, Ścibisz A, Pawlak M, Filipiak KJ, Opolski G. Cardiol J; 2013 Oct; 20(3):247-53. PubMed ID: 23788298 [Abstract] [Full Text] [Related]
14. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial. Liistro F, Porto I, Angioli P, Grotti S, Ducci K, Falsini G, Bolognese L. Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449 [Abstract] [Full Text] [Related]
15. The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans. Papafaklis MI, Bourantas CV, Theodorakis PE, Katsouras CS, Naka KK, Fotiadis DI, Michalis LK. JACC Cardiovasc Interv; 2010 Nov; 3(11):1181-9. PubMed ID: 21087755 [Abstract] [Full Text] [Related]
16. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography. Kim S, Kim JS, Shin DH, Kim BK, Ko YG, Choi D, Cho YK, Nam CW, Hur SH, Jang Y, Hong MK. Am J Cardiol; 2013 Jan 01; 111(1):1-5. PubMed ID: 23040589 [Abstract] [Full Text] [Related]
17. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study. Adriaenssens T, Dens J, Ughi G, Coosemans M, Onsea K, Dubois C, Sinnaeve P, Vrolix M, Desmet W. EuroIntervention; 2011 May 01; 7 Suppl K():K100-5. PubMed ID: 22027717 [Abstract] [Full Text] [Related]
19. Assessment by optical coherence tomography of stent struts across side branch. -Comparison of bare-metal stents and drug-elution stents.-. Liu Y, Imanishi T, Kubo T, Tanaka A, Kitabata H, Tanimoto T, Ino Y, Ikejima H, Tsujioka H, Komukai K, Ishibashi K, Kashiwagi M, Ozaki Y, Hirata K, Mizukoshi M, Akasaka T. Circ J; 2011 May 01; 75(1):106-12. PubMed ID: 21041972 [Abstract] [Full Text] [Related]
20. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography. Li S, Gai L, Yang T, Zhang L, Xu X, Bai Q, Xu H, Wang Y. Catheter Cardiovasc Interv; 2013 Apr 01; 81(5):768-75. PubMed ID: 22639418 [Abstract] [Full Text] [Related] Page: [Next] [New Search]